A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patientsClaudia Alteri, Carlo Federico Perno, Valeria Fox et al.|Communications Biology|2022Cited by 33
Genomic Evolution of Sars-Cov-2 in Molnupiravir-Treated Patients Compared to Paxlovid-Treated and Drug-Naïve Patients: A Proof-of-Concept StudyClaudia Alteri, Carlo Federico Perno, Valeria Fox et al.|Research Square|2022Cited by 4
OC-2 Modena and Emilia Romagna HIV surveillance: the application of ECDC HIV modelling toolMarianna Menozzi, Cristina Mussini, A Cervo et al.|Unknown|2024Cited by 1
P12. Retrospective comparative study of cefazolin and oxacillin in MSSA infections in patients with end-stage renal failure and dialysisSara Esperti, Erica Franceschini, Marianna Menozzi et al.|JAC-Antimicrobial Resistance|2025Cited by 0
Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapyMaria Naddeo, Francesca Bonifazi, Roberta Roncarati et al.|Haematologica|2026Cited by 0